Extrarenal volume depletion is a possible reason for low blood pressure, high aldosterone excretion, and potassium loss.

Results: the results show that AQP2 is restricted in the renal collecting duct. There is no expression in the extrarenal tissues.

Selective targeting of drugs to kidneys may enable an increased renal effectiveness combined with a reduction of extrarenal toxicity.